Medical Device News Magazine

Spinal Elements Announces First Clinical Use of the Lucent® 3D Lumbar Interbody System

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Spinal Elements, a spine technology company, today announced that the Lucent 3D Lumbar Interbody System has been successfully used in its first clinical cases with Dr. Thomas Noh, Neurosurgeon at Hawaii Pacific Health and Assistant Clinical Professor at the John A. Burns School of Medicine (JABSOM) at the University of Hawaii and Dr. Douglas H. Musser, D.O. at Youngstown Orthopedics Associates in Canfield, Ohio.

The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence. The resulting Lucent 3D implant is comprised of a strut-and-lattice structure with a bone graft chamber access lid designed to allow the surgeon to deliver a large amount of tightly packed graft inside the interbody structure, maximizing the amount of graft material available for fusion. Furthermore, when the access lid to the graft chamber is closed, the lid is designed to maximize surface area in contact with the vertebral endplates. Provided in both straight and curved designs, the interbody device is designed to be placed through an open or MIS posterior approach.

Dr. Noh commented, “The Lucent 3D Interbody is a novel and useful surgical option in my practice. The curved implant was easy to insert and helped to maintain lordosis. Knowing that there is tightly packed graft inside the cage provides additional confidence that a successful fusion will occur.”

Jason Blain, CEO of Spinal Elements, stated, “We are thrilled to share this technology with the surgical community. Lucent 3D’s novel design is meant to address subsidence and the amount of bone graft material available for fusion – two clinical challenges surgeons note exist with other 3D-printed interbody devices. We are pleased to offer additional innovative titanium interbody devices to our expansive and best-in-class product portfolio, adding to our long tradition of innovation in material science, novel designs, and leadership. We truly can answer any need for posterior lumbar fusion and continue to build on our procedural solutions.”

After finishing his first several Lucent 3D cases, Dr. Musser commented, “The design and structure of the Lucent 3D cage have provided a biologic containment area that has enabled me to place more graft material than traditional PLIF and TLIF cages. The Lucent 3D cage also has excellent visualization on both A/P and Lateral views when using fluoroscopy.”

Spinal Elements announced FDA clearance of the Lucent 3D system in April of this year and expects to expand on Lucent 3D’s graft containment concept in other clinical applications.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”